These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21002166)

  • 1. Mistreatment of congenital hemolytic disease (erythroblastosis fetalis) by transfusions of Rh-positive blood and maternal serum; a case report.
    WIENER AS; HYMAN MA
    J Pediatr; 1946 Oct; 29(4):498-503. PubMed ID: 21002166
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenesis of congenital hemolytic disease (erythroblastosis fetalis); illustrative case histories of Rh sensitization.
    WIENER AS; SONN EB
    Am J Dis Child (1911); 1946 Jan; 71():25-40. PubMed ID: 21018126
    [No Abstract]   [Full Text] [Related]  

  • 3. Practical application of the Rh factor in congenital hemolytic anemia of the newborn (erythroblastosis fetalis), habitual abortion, and blood transfusions.
    HAYMOND JL; GIORDANO AS
    J Indiana State Med Assoc; 1946 Sep; 39():429-35. PubMed ID: 20996186
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythroblastosis fetalis due to maternal sensitization to Hr factor by blood transfusion.
    GOODMAN HL
    J Med Soc N J; 1962 Aug; 59():468-70. PubMed ID: 13900306
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of erythroblastosis fetalis, with special reference to sensitization to Rh-Hr factors other than Rho.
    BRANCATO GJ; WEXLER IB; WIENER AS
    J Pediatr; 1956 Oct; 49(4):381-93. PubMed ID: 13358028
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemolytic disease of the newborn infant caused by maternal sensitization to the blood factor hr, report of two cases with special reference to the etiologic significance of multiple blood transfusions in Rh positive women prior to gestation.
    GRUNDORFER J
    Blood; 1953 Jul; 8(7):609-19. PubMed ID: 13059046
    [No Abstract]   [Full Text] [Related]  

  • 7. [Erythroblastosis fetalis with combined incompatibility within the Rhesus and ABO systems].
    LEBECH PE; THOMSEN B
    Ugeskr Laeger; 1962 Feb; 124():245-7. PubMed ID: 14463265
    [No Abstract]   [Full Text] [Related]  

  • 8. Prediction of the occurrence of erythroblastosis fetalis by antenatal Rh testing and its treatment by complete exchange transfusion.
    WIENER AS
    Pittsbg Med Bull; 1946 Nov; 35(39):778-86. PubMed ID: 20281084
    [No Abstract]   [Full Text] [Related]  

  • 9. [Considerations on 20 cases of hemolytic disease of the newborn treated by Rh negative blood transfusions].
    REVOL L; VIALLET H
    Lyon Med; 1949 Aug; 182(32):97. PubMed ID: 18139637
    [No Abstract]   [Full Text] [Related]  

  • 10. The Rh factor in hemolytic disease of the newborn.
    KAUMP DH
    Linacre Q; 1947 Jan; 14(1):1-8. PubMed ID: 20294850
    [No Abstract]   [Full Text] [Related]  

  • 11. The Rh factors in hemolytic disease of the newborn.
    NUNN JA
    Tex State J Med; 1947 Apr; 42(12):687-90. PubMed ID: 20291701
    [No Abstract]   [Full Text] [Related]  

  • 12. The Rh factor and erythroblastosis.
    SNELLING CE
    Can Med Assoc J; 1947 Jan; 56(1):47-51. PubMed ID: 20277520
    [No Abstract]   [Full Text] [Related]  

  • 13. [Case of fetal erythroblastosis, due to incompatibility of blood groups A and B, and having complete agreement of Rh factor].
    BIELICKA I; GRONIOWSKI J
    Pediatr Pol; 1949; 23(7-8):717-23. PubMed ID: 15417256
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fetal erythroblastosis following Rh sensitization by smallest blood quantity].
    STARK G
    Dtsch Med Wochenschr; 1951 Apr; 76(15):517-22. PubMed ID: 14840148
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fetal erythroblastosis in the light of Rh factor].
    LANGLOIS M; BASTARACHE A
    Laval Med; 1948 Jun; 13(6):750-70. PubMed ID: 18870149
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of passive Rh isosensitization in the newborn (erythroblastosis fetalis) with Rh-positive blood.
    FRANKOWSKI C; DARROW RR
    J Am Med Womens Assoc; 1946 Oct; 1(7):207-9. PubMed ID: 20274068
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fetal erythroblastosis and the Rh factor].
    GYONGYOSSY A
    Gynaecologia; 1948 Jul; 126(1):21-32. PubMed ID: 18873514
    [No Abstract]   [Full Text] [Related]  

  • 18. [DIAGNOSTIC PROBLEM OF NEONATAL HEMOLYTIC DISEASE DUE TO ANTIGENS OTHER THAN D].
    DAZZI L; MONTENOVESI P; PASQUALIN U
    Fracastoro; 1965; 58():129-35. PubMed ID: 14321320
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemolytic disease in newborn infants associated with sensitization to Rh antigen].
    TABOLIN VA; UMNOVA MA
    Vopr Okhr Materin Det; 1962 Jan; 7():28-31. PubMed ID: 13918830
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of Rh-positive blood cells in the treatment of erythroblastosis fetalis.
    DANIS PG; ETO JK; SENNOTT JS
    J Pediatr; 1946 Apr; 28():457-61. PubMed ID: 21023186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.